We are live on ! Find out more
GWP

Gen-Wealth Partners Portfolio holdings

AUM $317M
1-Year Est. Return 17.24%
This Fund
S&P 500
This Quarter Est. Return
+2.64%
1 Year Est. Return
+17.24%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$312M
AUM Growth
+$15.9M
Cap. Flow
+$428M
Cap. Flow %
137.16%
Top 10 Hldgs %
28.62%
Holding
736
New
55
Increased
186
Reduced
212
Closed
47

Top Sells

Rank Stock Value
1
QUAL icon
iShares MSCI USA Quality Factor ETF
QUAL
+$3.22M
2
ACN icon
Accenture
ACN
+$855K
3
FDS icon
Factset
FDS
+$731K
4
PEP icon
PepsiCo
PEP
+$552K
5
KEY icon
KeyCorp
KEY
+$537K

Sector Composition

Rank Sector Weight
1 Technology 8.69%
2 Industrials 7.49%
3 Financials 7.05%
4 Healthcare 6.74%
5 Consumer Staples 6.2%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BSX icon
126
Boston Scientific
BSX
$73.4B
$526K 0.17%
5,519
-4,712
-46% -$462K
PLD icon
127
Prologis
PLD
$131B
$506K 0.16%
3,967
+2,814
+244% +$351K
CMCSA icon
128
Comcast
CMCSA
$88.8B
$505K 0.16%
16,889
-11,476
-40% -$327K
HII icon
129
Huntington Ingalls Industries
HII
$13.2B
$500K 0.16%
1,470
+1,138
+343% +$353K
CL icon
130
Colgate-Palmolive
CL
$74.2B
$491K 0.16%
6,215
-2,120
-25% -$166K
NVO
131
Novo Nordisk
NVO
$209B
$490K 0.16%
9,637
-6,382
-40% -$326K
GEHC icon
132
GE HealthCare
GEHC
$33B
$490K 0.16%
5,976
+4,581
+328% +$357K
WPC icon
133
W.P. Carey
WPC
$16B
$487K 0.16%
7,572
+146
+2% +$9.72K
RTX icon
134
RTX Corp
RTX
$303B
$483K 0.15%
2,633
-34
-1% -$5.91K
CHRW icon
135
C.H. Robinson
CHRW
$17.4B
$482K 0.15%
2,998
-1,451
-33% -$214K
ACA icon
136
Arcosa
ACA
$7.11B
$480K 0.15%
4,517
+3,622
+405% +$366K
LIN icon
137
Linde
LIN
$225B
$477K 0.15%
1,119
-407
-27% -$174K
ESGU icon
138
iShares ESG Aware MSCI USA ETF
ESGU
$18.4B
$474K 0.15%
3,179
-723
-19% -$107K
CE icon
139
Celanese
CE
$4.8B
$465K 0.15%
10,987
+8,390
+323% +$342K
BIP icon
140
Brookfield Infrastructure Partners
BIP
$17.6B
$463K 0.15%
13,316
+10,558
+383% +$368K
HCA icon
141
HCA Healthcare
HCA
$89.3B
$462K 0.15%
989
+638
+182% +$296K
CBRE icon
142
CBRE Group
CBRE
$41.9B
$458K 0.15%
2,846
+2,322
+443% +$365K
CAH icon
143
Cardinal Health
CAH
$55.4B
$456K 0.15%
2,220
-1,040
-32% -$196K
BR icon
144
Broadridge
BR
$19.7B
$456K 0.15%
2,043
+1,581
+342% +$361K
SOLV icon
145
Solventum
SOLV
$14.4B
$445K 0.14%
5,621
+4,514
+408% +$346K
LOW icon
146
Lowe's Companies
LOW
$122B
$442K 0.14%
1,834
-527
-22% -$127K
GL icon
147
Globe Life
GL
$14.3B
$440K 0.14%
+3,149
New +$427K
MPLX icon
148
MPLX
MPLX
$59.4B
$438K 0.14%
8,207
+6,452
+368% +$336K
CACI icon
149
CACI
CACI
$14.3B
$438K 0.14%
821
+649
+377% +$367K
SHOP icon
150
Shopify
SHOP
$198B
$437K 0.14%
2,716
+2,156
+385% +$346K

Similar funds

Gen-Wealth Partners's Q4 2025 Portfolio in Review

As of Q4 2025, Gen-Wealth Partners held 736 positions worth $312M, up 5.4% from $296M the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Gen-Wealth Partners deployed $428M of net new capital in Q4 2025, opening 55 new positions and adding to 186 existing holdings. Its largest new stake was Vanguard Total Bond Market: 152,652 shares worth $153K.

By sector, the portfolio is most concentrated in Technology at 8.7% of assets, down from 9.3% a quarter earlier, followed by Industrials and Financials.

On the sell side, the largest reduction was iShares MSCI USA Quality Factor ETF, an estimated $3.22M trimmed.

  • Gen-Wealth Partners's largest Q4 2025 buy was Vanguard Total Bond Market: 152,652 shares worth $153K.
  • Gen-Wealth Partners added most to State Street SPDR S&P 500 ETF Trust in Q4 2025, an estimated $176M increase.
  • Gen-Wealth Partners's biggest Q4 2025 reduction was iShares MSCI USA Quality Factor ETF, cutting an estimated $3.22M.
  • Gen-Wealth Partners fully exited KeyCorp in Q4 2025, selling an estimated $537K.
  • Gen-Wealth Partners's ten largest holdings make up 29% of its $312M portfolio in Q4 2025.
  • Gen-Wealth Partners opened 55 new positions and closed 47 in Q4 2025.
  • Gen-Wealth Partners's portfolio value rose 5.4% quarter-over-quarter to $312M.

Based on Gen-Wealth Partners's 13F filing for Q4 2025, filed 13 Feb 2026.